Abnormalities in micturition: Difference between revisions
Jump to navigation
Jump to search
m (Mehrian.jafari moved page Abnormalities in micturation to Abnormalities in micturition) |
|||
Line 40: | Line 40: | ||
|- | |- | ||
! rowspan="10" |[[Inflammatory]] | ! rowspan="10" |[[Inflammatory]] | ||
! rowspan="3" |[[Dermatological lesions|Dermatological disorders]] | ! rowspan="3" style="background: #DCDCDC; text-align: center;" |[[Dermatological lesions|Dermatological disorders]] | ||
![[Lichen sclerosus]] | !style="background: #DCDCDC; text-align: center;" |[[Lichen sclerosus]] | ||
!- | !- | ||
!- | !- | ||
Line 59: | Line 59: | ||
! | ! | ||
|- | |- | ||
![[Behcet's syndrome]] | !style="background: #DCDCDC; text-align: center;" |[[Behcet's syndrome]] | ||
!- | !- | ||
!- | !- | ||
Line 77: | Line 77: | ||
! | ! | ||
|- | |- | ||
![[Contact dermatitis]] | !style="background: #DCDCDC; text-align: center;" |[[Contact dermatitis]] | ||
!- | !- | ||
!- | !- | ||
Line 95: | Line 95: | ||
! | ! | ||
|- | |- | ||
! rowspan="7" |[[Infectious disease|Infectious diseases]] | ! rowspan="7" style="background: #DCDCDC; text-align: center;" |[[Infectious disease|Infectious diseases]] | ||
![[Cystitis]] | !style="background: #DCDCDC; text-align: center;" |[[Cystitis]] | ||
!- | !- | ||
!+ | !+ | ||
Line 114: | Line 114: | ||
! | ! | ||
|- | |- | ||
![[Urethritis]] | !style="background: #DCDCDC; text-align: center;" |[[Urethritis]] | ||
!- | !- | ||
!+ | !+ | ||
Line 132: | Line 132: | ||
! | ! | ||
|- | |- | ||
![[Pyelonephritis]] | !style="background: #DCDCDC; text-align: center;" |[[Pyelonephritis]] | ||
!+ | !+ | ||
!+ | !+ | ||
Line 150: | Line 150: | ||
! | ! | ||
|- | |- | ||
![[Vulvovaginitis]] | !style="background: #DCDCDC; text-align: center;" |[[Vulvovaginitis]] | ||
!- | !- | ||
!+ | !+ | ||
Line 168: | Line 168: | ||
! | ! | ||
|- | |- | ||
![[Cervicitis]] | !style="background: #DCDCDC; text-align: center;" |[[Cervicitis]] | ||
!+/- | !+/- | ||
!+ | !+ | ||
Line 186: | Line 186: | ||
! | ! | ||
|- | |- | ||
![[Prostatitis]] | !style="background: #DCDCDC; text-align: center;" |[[Prostatitis]] | ||
!+ | !+ | ||
!+/- | !+/- | ||
Line 204: | Line 204: | ||
! | ! | ||
|- | |- | ||
![[Epididymoorchitis]] | !style="background: #DCDCDC; text-align: center;" |[[Epididymoorchitis]] | ||
!- | !- | ||
!+/- | !+/- | ||
Line 223: | Line 223: | ||
|- | |- | ||
! rowspan="11" |Non-[[inflammatory]] | ! rowspan="11" |Non-[[inflammatory]] | ||
! rowspan="2" |[[Anatomic]] | ! rowspan="2"style="background: #DCDCDC; text-align: center;" |[[Anatomic]] | ||
![[Urethral stricture]] | !style="background: #DCDCDC; text-align: center;" |[[Urethral stricture]] | ||
! | ! | ||
! | ! | ||
Line 242: | Line 242: | ||
! | ! | ||
|- | |- | ||
![[Benign prostatic hyperplasia|Benign prostatic hyperplasia (BPH)]] | !style="background: #DCDCDC; text-align: center;" |[[Benign prostatic hyperplasia|Benign prostatic hyperplasia (BPH)]] | ||
! | ! | ||
! | ! | ||
Line 260: | Line 260: | ||
! | ! | ||
|- | |- | ||
! rowspan="2" |[[Drug]] | ! rowspan="2" style="background: #DCDCDC; text-align: center;" |[[Drug]] | ||
![[Spermicide|Spermicides]] | !style="background: #DCDCDC; text-align: center;" |[[Spermicide|Spermicides]] | ||
! | ! | ||
! | ! | ||
Line 279: | Line 279: | ||
! | ! | ||
|- | |- | ||
![[Cyclophosphamide]] | !style="background: #DCDCDC; text-align: center;" |[[Cyclophosphamide]] | ||
! | ! | ||
! | ! | ||
Line 297: | Line 297: | ||
! | ! | ||
|- | |- | ||
! rowspan="2" |[[Endocrine disorders]] | ! rowspan="2" style="background: #DCDCDC; text-align: center;" |[[Endocrine disorders]] | ||
![[Atrophic vaginitis]] | !style="background: #DCDCDC; text-align: center;" |[[Atrophic vaginitis]] | ||
! | ! | ||
! | ! | ||
Line 316: | Line 316: | ||
! | ! | ||
|- | |- | ||
![[Endometriosis]] | !style="background: #DCDCDC; text-align: center;" |[[Endometriosis]] | ||
! | ! | ||
! | ! | ||
Line 334: | Line 334: | ||
! | ! | ||
|- | |- | ||
! rowspan="2" |[[Malignancy]] | ! rowspan="2"style="background: #DCDCDC; text-align: center;" |[[Malignancy]] | ||
![[Bladder cancer]] | !style="background: #DCDCDC; text-align: center;" |[[Bladder cancer]] | ||
! | ! | ||
! | ! | ||
Line 353: | Line 353: | ||
! | ! | ||
|- | |- | ||
![[Vulvovaginal disorders|Vulvovaginal cancer]] | !style="background: #DCDCDC; text-align: center;" |[[Vulvovaginal disorders|Vulvovaginal cancer]] | ||
! | ! | ||
! | ! | ||
Line 371: | Line 371: | ||
! | ! | ||
|- | |- | ||
! rowspan="3" |[[Iatrogenic]] | ! rowspan="3"style="background: #DCDCDC; text-align: center;" |[[Iatrogenic]] | ||
![[Genitourinary system|Genitourinary instrumentation]] | !style="background: #DCDCDC; text-align: center;" |[[Genitourinary system|Genitourinary instrumentation]] | ||
! | ! | ||
! | ! | ||
Line 390: | Line 390: | ||
! | ! | ||
|- | |- | ||
![[Pelvic]] [[irradiation]] | !style="background: #DCDCDC; text-align: center;" |[[Pelvic]] [[irradiation]] | ||
! | ! | ||
! | ! | ||
Line 408: | Line 408: | ||
! | ! | ||
|- | |- | ||
![[Trauma]] | !style="background: #DCDCDC; text-align: center;" |[[Trauma]] | ||
! | ! | ||
! | ! |
Revision as of 20:14, 27 June 2018
Micturation Abnormalities Microchapters |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:
Overview
Classification
Causes
Abnormalities of Micturation Differential Diagnosis
Differentiating the diseases that can cause abnormality in micturation:
Diseases | Clinical manifestations | Para-clinical findings | Gold standard | Additional findings | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Physical examination | |||||||||||||||||
Lab Findings | Imaging | |||||||||||||||||
Low back pain | Fever | Urinary symptoms | Supra-pubic tenderness | Skin lesions | Other | CBC | Electrolytes | Urinalysis | Ultrasonography | CT scan | Other | |||||||
Dribbling | Hesitancy | Nocturia | ||||||||||||||||
Inflammatory | Dermatological disorders | Lichen sclerosus | - | - | - | + | - | - | - | |||||||||
Behcet's syndrome | - | - | - | + | - | - | ||||||||||||
Contact dermatitis | - | - | - | + | - | - | ||||||||||||
Infectious diseases | Cystitis | - | + | +/- | + | - | + | |||||||||||
Urethritis | - | + | - | + | - | +/- | ||||||||||||
Pyelonephritis | + | + | - | + | - | +/- | ||||||||||||
Vulvovaginitis | - | + | + | + | - | - | ||||||||||||
Cervicitis | +/- | + | +/- | - | - | + | ||||||||||||
Prostatitis | + | +/- | + | + | + | + | ||||||||||||
Epididymoorchitis | - | +/- | + | + | ||||||||||||||
Non-inflammatory | Anatomic | Urethral stricture | ||||||||||||||||
Benign prostatic hyperplasia (BPH) | ||||||||||||||||||
Drug | Spermicides | |||||||||||||||||
Cyclophosphamide | ||||||||||||||||||
Endocrine disorders | Atrophic vaginitis | |||||||||||||||||
Endometriosis | ||||||||||||||||||
Malignancy | Bladder cancer | |||||||||||||||||
Vulvovaginal cancer | ||||||||||||||||||
Iatrogenic | Genitourinary instrumentation | |||||||||||||||||
Pelvic irradiation | ||||||||||||||||||
Trauma |